PYCARD Knockout HEK293T Cell Pool

热销产品

undefined
undefined
+
  • undefined
  • undefined

编号 :

LM01700103490

产品编号: LM01700103490

市场价

销售价格:  ¥ 5499

数量
-
+

库存剩余

联系我们订购

抗体定制服务咨询

隐藏域元素占位

  • 产品描述
  • 细胞复苏
  • 细胞传代
  • 细胞冻存
  • 抗体验证结果
    • 品牌: ELEMok138cn太阳集团529
    • 商品名称: PYCARD Knockout HEK293T Cell Pool
    • 商品编号: LM01700103490
    • Gene Symbol: PYCARD ASC CARD5 TMS1
    • Ensembl ID: ENSG00000103490
    • Uniprot ID: Q9ULZ3
    • 宿主细胞 / 类型: HEK293T/人胚肾细胞
    • NCBI Gene ID: 29108
    • 规格: 1×10^6 cells/ 冻存管
    • 筛选标记: N/A
    • 生长特性: 贴壁细胞,上皮细胞样
    • 培养条件: 37℃,5% CO2 的培养箱,1/3 到 1/4 传代
    • 倍增时间: ~24-36 hours
    • 生长培养基: DMEM+10% FBS+1% P/S
    • 参考换液频率: 2~3次/周
    • 支原体检测结果: 阴性
    • 敲除效率(Sanger测序): >70%
    • 蛋白质组验证结果: N/A
    • 抗体货号: 添加中
    • 目标基因介绍: Functions as key mediator in apoptosis and inflammation. Promotes caspase-mediated apoptosis involving predominantly caspase-8 and also caspase-9 in a probable cell type-specific manner. Involved in activation of the mitochondrial apoptotic pathway, promotes caspase-8-dependent proteolytic maturation of BID independently of FADD in certain cell types and also mediates mitochondrial translocation of BAX and activates BAX-dependent apoptosis coupled to activation of caspase-9, -2 and -3. Involved in macrophage pyroptosis, a caspase-1-dependent inflammatory form of cell death and is the major constituent of the ASC pyroptosome which forms upon potassium depletion and rapidly recruits and activates caspase-1. In innate immune response believed to act as an integral adapter in the assembly of the inflammasome which activates caspase-1 leading to processing and secretion of proinflammatory cytokines. The function as activating adapter in different types of inflammasomes is mediated by the pyrin and CARD domains and their homotypic interactions. Required for recruitment of caspase-1 to inflammasomes containing certain pattern recognition receptors, such as NLRP2, NLRP3, AIM2 and probably IFI16. In the NLRP1 and NLRC4 inflammasomes seems not be required but facilitates the processing of procaspase-1. In cooperation with NOD2 involved in an inflammasome activated by bacterial muramyl dipeptide leading to caspase-1 activation. May be involved in DDX58-triggered proinflammatory responses and inflammasome activation. Isoform 2 may have a regulating effect on the function as inflammasome adapter. Isoform 3 seems to inhibit inflammasome-mediated maturation of interleukin-1 beta. In collaboration with AIM2 which detects cytosolic double-stranded DNA may also be involved in a caspase-1-independent cell death that involves caspase-8. In adaptive immunity may be involved in maturation of dendritic cells to stimulate T-cell immunity and in cytoskeletal rearrangements coupled to chemotaxis and antigen uptake may be involved in post-transcriptional regulation of the guanine nucleotide exchange factor DOCK2; the latter function is proposed to involve the nuclear form. Also involved in transcriptional activation of cytokines and chemokines independent of the inflammasome; this function may involve AP-1, NF-kappa-B, MAPK and caspase-8 signaling pathways. For regulation of NF-kappa-B activating and inhibiting functions have been reported. Modulates NF-kappa-B induction at the level of the IKK complex by inhibiting kinase activity of CHUK and IKBK. Proposed to compete with RIPK2 for association with CASP1 thereby down-regulating CASP1-mediated RIPK2-dependent NF-kappa-B activation and activating interleukin-1 beta processing. Modulates host resistance to DNA virus infection, probably by inducing the cleavage of and inactivating CGAS in presence of cytoplasmic double-stranded DNA (PubMed:28314590).
    • 细胞开发路径: 采用CRISPR-RNP方法生成稳定KO Cell Pool;Sanger 测序结果显示KO Cell Pool敲除效率>70%。
    • 应用: 高敲除效率的基因敲除细胞池(KO Cell Pool),特别适用于初步功能分析、复杂疾病模型的开发、精准药物筛选以及广泛的基因发现研究。KO pool能够无需繁琐的单克隆挑选过程,直接应用于多种类型的测定和分析,大幅提升实验效率。
    关键词:
    • PYCARD ASC CARD5 TMS1
  • 01.  在 37℃水浴中预热完全培养基。
    02.  将冻存管在 37℃水浴中解冻 1-2 分钟。
    03.  将冻存管转移到生物安全柜中,并用 70% 乙醇擦拭表面。
    04.  拧开冻存管管盖,将细胞悬液轻轻转移到含有 9mL 完全培养基的无菌离心管中。
    05.  在室温下以 125g 离心 5-7 分钟,弃上清。
    06.  用 5mL 的完整培养基重悬细胞沉淀,将细胞悬液转移到 T25 培养瓶中。
    07.  将细胞转移到 37℃,5% CO2 的培养箱中培养。
    08.  参考传代比例:1/3 到 1/4 传代,2-3 天长满。

  • 01.  待培养瓶中细胞汇合度至 80%-90% 以上,可进行细胞传代。
    02.  将培养基、PBS、胰酶(0.25%Trypsin_EDTA Gibco 25200-056) 等从 4℃冰箱中拿出, 置于 37℃水浴中温度接近 37℃时取出并在瓶子表面喷洒 75% 酒精后置于生物安全柜中。

    03.  从培养箱中取出待传代的培养瓶,瓶身喷洒 75% 酒精后置于生物安全柜中。
    04.  为避免冲散细胞,沿培养瓶上壁 PBS 润洗细胞,清洗细胞后弃去,T25 加 2mL。
    05.  加入对应体积的胰酶(T75 加 1.5mL, T25 加 0.5mL)  ,并轻轻晃动瓶身使胰酶平铺满细胞 底部。可根据实际情况适当增加或减少用量。约 1-2min 后大部分细胞脱落时,加入对应体积的完全培养基终止消化,并用 5mL 移液管轻轻吹打至细胞全部脱落。
    06.  将细胞悬液转移至 15mL 离心管,悬液 300g 离心 5min,弃上清。
    07.  移取 5mL 完全培养基重悬细胞,按需求调整接种比例,并补充培养瓶中完全培养基,T75 加至 13-15mL,T25 加至 5mL,加 1% 双抗。
    08.  盖上瓶盖拧紧后轻轻晃动瓶身,使细胞混合均匀后置于 37℃,5% CO2 培养箱中。

  • 01.  准备冻存液,并提前预冷。
    02.  确保待冻存的细胞满足冻存要求,用显微镜检查以下状态:健康的外观及形态特征、所处生 长周期(对数晚期)、无污染或衰退迹象。
    03.  对细胞进行消化及离心处理(具体步骤参考传代培养流程)
    04.  按照每管 1mL 的量添加冻存液重悬细胞,吹打均匀后分装至冻存管。
    05.  将细胞放在程序降温盒中,在 -80℃冰箱中冷冻。
    06.  后续将细胞转移到液氮罐中,以便长期储存。

  • 抗体验证中

产品类型: 基因敲除细胞池(相分离相关靶点)

细胞系信息

Gene Symbol

PYCARD ASC CARD5 TMS1

NCBI Gene ID

29108

Ensembl ID

ENSG00000103490

Uniprot ID

Q9ULZ3

筛选标记

N/A

宿主细胞 / 类型

HEK293T/人胚肾细胞

规格

1×10^6 cells/ 冻存管

生长培养基

DMEM+10% FBS+1% P/S

生长特性

贴壁细胞,上皮细胞样

培养条件

37℃,5% CO2 的培养箱,1/3 到 1/4 传代

倍增时间

~24-36 hours

参考换液频率

2~3次/周

支原体检测结果

阴性

敲除验证

敲除效率(Sanger测序)

>70%

蛋白质组验证结果

N/A

抗体货号

添加中

抗体验证结果

抗体验证中

细胞系说明

目标基因介绍

Functions as key mediator in apoptosis and inflammation. Promotes caspase-mediated apoptosis involving predominantly caspase-8 and also caspase-9 in a probable cell type-specific manner. Involved in activation of the mitochondrial apoptotic pathway, promotes caspase-8-dependent proteolytic maturation of BID independently of FADD in certain cell types and also mediates mitochondrial translocation of BAX and activates BAX-dependent apoptosis coupled to activation of caspase-9, -2 and -3. Involved in macrophage pyroptosis, a caspase-1-dependent inflammatory form of cell death and is the major constituent of the ASC pyroptosome which forms upon potassium depletion and rapidly recruits and activates caspase-1. In innate immune response believed to act as an integral adapter in the assembly of the inflammasome which activates caspase-1 leading to processing and secretion of proinflammatory cytokines. The function as activating adapter in different types of inflammasomes is mediated by the pyrin and CARD domains and their homotypic interactions. Required for recruitment of caspase-1 to inflammasomes containing certain pattern recognition receptors, such as NLRP2, NLRP3, AIM2 and probably IFI16. In the NLRP1 and NLRC4 inflammasomes seems not be required but facilitates the processing of procaspase-1. In cooperation with NOD2 involved in an inflammasome activated by bacterial muramyl dipeptide leading to caspase-1 activation. May be involved in DDX58-triggered proinflammatory responses and inflammasome activation. Isoform 2 may have a regulating effect on the function as inflammasome adapter. Isoform 3 seems to inhibit inflammasome-mediated maturation of interleukin-1 beta. In collaboration with AIM2 which detects cytosolic double-stranded DNA may also be involved in a caspase-1-independent cell death that involves caspase-8. In adaptive immunity may be involved in maturation of dendritic cells to stimulate T-cell immunity and in cytoskeletal rearrangements coupled to chemotaxis and antigen uptake may be involved in post-transcriptional regulation of the guanine nucleotide exchange factor DOCK2; the latter function is proposed to involve the nuclear form. Also involved in transcriptional activation of cytokines and chemokines independent of the inflammasome; this function may involve AP-1, NF-kappa-B, MAPK and caspase-8 signaling pathways. For regulation of NF-kappa-B activating and inhibiting functions have been reported. Modulates NF-kappa-B induction at the level of the IKK complex by inhibiting kinase activity of CHUK and IKBK. Proposed to compete with RIPK2 for association with CASP1 thereby down-regulating CASP1-mediated RIPK2-dependent NF-kappa-B activation and activating interleukin-1 beta processing. Modulates host resistance to DNA virus infection, probably by inducing the cleavage of and inactivating CGAS in presence of cytoplasmic double-stranded DNA (PubMed:28314590).

细胞开发路径

采用CRISPR-RNP方法生成稳定KO Cell Pool;Sanger 测序结果显示KO Cell Pool敲除效率>70%。

应用

高敲除效率的基因敲除细胞池(KO Cell Pool),特别适用于初步功能分析、复杂疾病模型的开发、精准药物筛选以及广泛的基因发现研究。KO pool能够无需繁琐的单克隆挑选过程,直接应用于多种类型的测定和分析,大幅提升实验效率。

细胞培养说明

细胞复苏

01.  在 37℃水浴中预热完全培养基。
02.  将冻存管在 37℃水浴中解冻 1-2 分钟。
03.  将冻存管转移到生物安全柜中,并用 70% 乙醇擦拭表面。
04.  拧开冻存管管盖,将细胞悬液轻轻转移到含有 9mL 完全培养基的无菌离心管中。
05.  在室温下以 125g 离心 5-7 分钟,弃上清。
06.  用 5mL 的完整培养基重悬细胞沉淀,将细胞悬液转移到 T25 培养瓶中。
07.  将细胞转移到 37℃,5% CO2 的培养箱中培养。
08.  参考传代比例:1/3 到 1/4 传代,2-3 天长满。

细胞传代

01.  待培养瓶中细胞汇合度至 80%-90% 以上,可进行细胞传代。
02.  将培养基、PBS、胰酶(0.25%Trypsin_EDTA Gibco 25200-056) 等从 4℃冰箱中拿出, 置于 37℃水浴中温度接近 37℃时取出并在瓶子表面喷洒 75% 酒精后置于生物安全柜中。

03.  从培养箱中取出待传代的培养瓶,瓶身喷洒 75% 酒精后置于生物安全柜中。
04.  为避免冲散细胞,沿培养瓶上壁 PBS 润洗细胞,清洗细胞后弃去,T25 加 2mL。
05.  加入对应体积的胰酶(T75 加 1.5mL, T25 加 0.5mL)  ,并轻轻晃动瓶身使胰酶平铺满细胞 底部。可根据实际情况适当增加或减少用量。约 1-2min 后大部分细胞脱落时,加入对应体积的完全培养基终止消化,并用 5mL 移液管轻轻吹打至细胞全部脱落。
06.  将细胞悬液转移至 15mL 离心管,悬液 300g 离心 5min,弃上清。
07.  移取 5mL 完全培养基重悬细胞,按需求调整接种比例,并补充培养瓶中完全培养基,T75 加至 13-15mL,T25 加至 5mL,加 1% 双抗。
08.  盖上瓶盖拧紧后轻轻晃动瓶身,使细胞混合均匀后置于 37℃,5% CO2 培养箱中。

细胞冻存

01.  准备冻存液,并提前预冷。
02.  确保待冻存的细胞满足冻存要求,用显微镜检查以下状态:健康的外观及形态特征、所处生 长周期(对数晚期)、无污染或衰退迹象。
03.  对细胞进行消化及离心处理(具体步骤参考传代培养流程)
04.  按照每管 1mL 的量添加冻存液重悬细胞,吹打均匀后分装至冻存管。
05.  将细胞放在程序降温盒中,在 -80℃冰箱中冷冻。
06.  后续将细胞转移到液氮罐中,以便长期储存。

XML 地图